An experimental drug that is already in clinical trials for other diseases could disrupt a positive feedback loop that exacerbates pulmonary arterial hypertension, a dangerous and rapidly fatal condition for which there is ...
Over the last decade there has been a surge in the use of both medical-grade and consumer-grade wearable devices that measure an individual's physiology. The ability to monitor our own activities and health is more accessible ...
Mar 2, 2023
0
55
For people at high risk of contracting HIV, missing doses of their daily HIV prevention pills can have big consequences. In some cases, missing a pill can lead to lack of protection against the virus.
Feb 9, 2023
0
26
Turning a decades-old dogma on its head, new research from scientists at UC San Francisco and Stanford Medicine shows that the receptor for oxytocin, a hormone considered essential to forming social bonds, may not play the ...
Jan 27, 2023
0
96
Researchers of the Human Brain Project (HBP) have published a new study in Science Translational Medicine presenting advanced brain modeling methods for epilepsy clinical care. The article, which is featured on this week's ...
Jan 26, 2023
0
59
The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in place during the COVID-19 pandemic, ...
Jan 20, 2023
1
37
Adults with high levels of attention-deficit hyperactivity disorder (ADHD) symptoms are more likely to experience anxiety and depression than adults with high levels of autistic traits, according to new research led by psychologists ...
Jan 16, 2023
1
134
One of the most dreaded effects of the bite of the brown recluse spider (Loxosceles spp) is the appearance of a necrotic skin lesion, but a clinical study by Brazilian researchers recently reported in PLOS Neglected Tropical ...
Jan 11, 2023
0
103
A genetic test developed in a study at the University of Helsinki and Helsinki University Hospital identifies ovarian cancer patients who benefit from PARP inhibitors, a treatment option.
Jan 11, 2023
0
61
National Institutes of Health researchers have published an assessment of 13 studies that took a genotype-first approach to patient care. This approach contrasts with the typical phenotype-first approach to clinical research, ...
Jan 5, 2023
0
61
